Results 201 to 210 of about 115,075 (345)

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink, Dominique van Mil, Gozewijn D. Laverman, Hiddo J. L. Heerspink, Ron T. Gansevoort   +4 more
wiley   +1 more source

Rethinking Balanced Resuscitation in Trauma. [PDF]

J Clin Med
Anand T, Shin H, Ratnasekera A, Tran ML, Huckeby R, Butts L, Stejskal I, Magnotti LJ, Joseph B.   +8 more
europepmc   +1 more source

The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior

Neuron, 2010
T. Insel
semanticscholar   +1 more source

Population‐level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To estimate the impact of semaglutide 2.4 mg treatment on the risk of major adverse cardiovascular events (MACE) in adults with overweight/obesity in the United States based on the SELECT trial of patients with atherosclerotic cardiovascular disease.
Michael G. Nanna, Quan V. Doan, Anthony Fabricatore, Mads Faurby, Alasdair D. Henry, Azadeh Houshmand‐Oeregaard, Alina Levine, Ann Marie Navar, Thomas Scassellati Sforzolini, Joshua C. Toliver   +9 more
wiley   +1 more source

Idiopathic Arginine Vasopressin Deficiency With Mild and Reversible Hypercalcemia. [PDF]

Ochsner J
Malik A, Goyal A, Gupta R, Bhagat A.
europepmc   +1 more source

A comparison of the circulatory effects of angiotensin, vasopressin and adrenaline in the anaesthetized cat

, 1961
Gwenda R. Barer
openalex   +2 more sources

A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors

Diabetes, Obesity and Metabolism, EarlyView.
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley   +1 more source

Short-term effects of brachycephalic obstructive airway syndrome surgery on fitness and exercise in brachycephalic dogs. [PDF]

Front Vet Sci
Goossens J, Meyer-Lindenberg A, Zablotski Y, Schroers M.   +3 more
europepmc   +1 more source

The stimulant effect of cold on vasopressin release from the neurohypophysis in vitro. [PDF]

, 1965
W. W. Douglas, Ayako Ishida
openalex   +1 more source

Clinical, Laboratory, and Imaging Features Associated with Arginine Vasopressin Deficiency (Central Diabetes Insipidus) in Erdheim-Chester Disease (ECD). [PDF]

Cancers (Basel)
Vaid S, Estrada-Veras J, Gahl WA, Patronas N, Dave RH, Hannah-Shmouni F, O'Brien K, Shekhar S.   +7 more
europepmc   +1 more source